The market of chiral drugs: Chiral switches versus de novo e…
Well Cited
487
Citations133
Refs2017
Year
Search Works
Work Details
- DOI 10.1016/j.jpba.2017.07.008
- PMID https://pubmed.ncbi.nlm.nih.gov/28942107
- OpenAlex ID W2734647920
- Type Review
- Language EN
- Published 10 Jul 2017
- Volume 147
- Pages 323–340
- Source Journal of Pharmaceutical and Biomedical…
- Publisher Elsevier BV
- FWCI 3.92
- Countries 1
- Institutions 1
- Added 21 Jul 2017
- Updated 28 Oct 2026
External Links
MENU
0
The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds
Review 2017 EN
487
Citations
133
References
2
Authors
3.92
FWCI
Citations by Year
Last 10 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
2 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Andrea Calcaterra | Sapienza University of Rome (IT) | |
| 2 | Ilaria D’Acquarica Corresponding | Sapienza University of Rome (IT) |
Related Works
10Data: OpenAlex